article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

By partnering with executive search firms, organizations operating in the life sciences industry tap into a vast network of experienced professionals with the necessary expertise to excel in these demanding roles and professionals with deep experience identifying and assessing that talent.

Execution 416
article thumbnail

Holographic Light Field Displays

Strategy Driven

Unlike 3D films made for the cinema or stereoscopic televisions operating with glasses, such 3D displays require proprietary content combining as many as eight discrete images. Another technique uses a unique eye-sensing technology that constantly senses the position of your eyes and delivers a bright, clear 3D image to each one.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Information Technology's Dangerous Trend in Africa

Harvard Business Review

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. But in the IT industry, most Nigerian firms are well-positioned for any challenge. The farms are now IT labs.

article thumbnail

Innovation Should Be a Top Priority for Boards. So Why Isn’t It?

Harvard Business Review

This isn’t all that surprising given the level of innovation activity in these sectors, but directors operating in similarly disrupted sectors should take note. The effectiveness of board processes for supporting innovation is also positively correlated with overall board performance. Director Recruitment and Skills.

article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.

Energy 10
article thumbnail

Think Global, Not Emerging Markets, Century

Harvard Business Review

Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies. Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese.

article thumbnail

Predictive Medicine Depends on Analytics

Harvard Business Review

The positions are there for the taking. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They are collaborating with (sometimes highly unlikely) partners. They’re also sharing risk. But not for long.